Delivery Order SPE2DB22D1052-SPE2DB24FU9FH

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1052
    Indefinite Delivery Contract
  • SPE2DB22D1052-SPE2DB24FU9FH
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of pharmaceutical product "MENQUADFI VIAL 0.5ML" with a ceiling value of $5,712.31 and a period of performance through June 14, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a leading supplier of pharmaceutical products to the federal government, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill contracts with various government agencies, particularly the Department of Defense and Veterans Affairs healthcare systems.

Generated 9/12/24, 11:00 AM